Depression, a pervasive psychiatric disorder characterized by persistent sadness, loss of interest, and impaired cognitive function, has been long associated with adverse physical health effects, including disrupted sleep patterns, weakened immune function, and increased susceptibility to chronic diseases. The relationship between depression and cancer has been an active topic of investigation, with studies linking depression to heightened cancer risk and poorer disease prognosis. However, its specific influence on surgical outcomes has remained less explored until now.

The study utilizes extensive retrospective analysis using data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. By reviewing records of older patients diagnosed with colorectal, hepatobiliary, and pancreatic cancers, the researchers aimed to understand how a concurrent diagnosis of depression, within a 12-month window before or after cancer diagnosis, impacted post-surgical recovery. An important methodological innovation was the use of Medicare Part D prescription data to identify which patients had received antidepressant medications, enabling a distinction between treated and untreated depression in the surgical context.

The research cohort consisted of 32,726 patients, of which 1,731 were diagnosed with depression. Among these, 1,253 patients were prescribed antidepressants, while 478 were not. This stratification allowed the researchers to compare surgical outcomes across three groups: patients without depression, patients with treated depression, and patients with untreated depression. This granular approach provides richer insight into how pharmacologic management of depression interfaces with surgical resilience and recovery.

Outcomes were rigorously defined in terms of an “ideal” postoperative course, which included the absence of surgical complications, avoidance of protracted hospital stays, no readmissions within 90 days, and survival beyond 90 days post-surgery. This composite endpoint highlights a clinically meaningful benchmark emphasizing quality recovery rather than isolated metrics. The study’s findings demonstrate that patients suffering from depression, regardless of treatment status, generally experience poorer recovery trajectories compared to those without depression.

However, the data revealed a significant mitigating effect of antidepressant therapy. Patients receiving pharmacological treatment for depression exhibited notably better outcomes compared to their untreated counterparts. These improvements extended beyond clinical markers to include shorter hospital stays, reduced readmission rates, and lower postoperative mortality rates. Such findings underscore the potential of antidepressants not only to alleviate psychiatric symptoms but to foster physiological resilience during the vulnerable perioperative period.

The economic implications were equally striking. Patients without depression had the lowest average cost of surgical care, calculated at approximately $17,551. Those with treated depression experienced a modest increase of 7.3% in healthcare expenditures, while costs soared by over 10% for patients with untreated depression. This correlation between mental health treatment and reduced financial burden provides a compelling argument for integrating psychiatric care into surgical protocols, possibly alleviating strain on healthcare systems burdened by costly postoperative complications.

Exploring the potential mechanisms behind these observations, the investigators point to the well-documented tendency of depression to reduce adherence to medical regimens, including both pharmacological treatments and recommended lifestyle interventions. Depression’s detrimental impact on motivation and executive functioning may hinder patients’ ability to participate actively in their care plans, jeopardizing recovery. By treating depression, healthcare providers can potentially enhance patient engagement, promote self-care, and improve compliance with postoperative guidelines, thereby leading to better outcomes.

Furthermore, the impetus for this research emerged during the COVID-19 pandemic, which dramatically heightened awareness of mental health issues worldwide. The pandemic underscored the complex interplay between psychosocial stressors and physical illness, prompting researchers at The Ohio State University to investigate how mental health intersected with surgical outcomes. Recognizing health-related social needs, including food insecurity, job instability, and domestic violence, the team sought a broader understanding of the factors influencing recovery beyond purely biomedical variables.

While the study highlights the need for systematic depression screening in surgical candidates, it also acknowledges certain limitations. The use of antidepressant prescriptions as a proxy for depression treatment does not capture non-pharmacological interventions, such as psychotherapy or psychiatric care, which may also impact outcomes. In addition, the retrospective design limits causative conclusions, and future prospective studies are needed to validate these findings and explore the nuanced effects of different types and durations of depression management.

Importantly, the senior author, Dr. Timothy M. Pawlik, emphasizes that integrating mental health evaluation into preoperative planning could empower surgeons and healthcare teams to craft holistic, individualized treatments. Addressing psychological comorbidities proactively may help anticipate complications, reduce morbidity and mortality, and optimize patient-centered care. Patients are encouraged to acknowledge and communicate their mental health needs as part of their surgical journey to achieve the best possible recovery.

This study represents a significant step toward bridging the gap between mental and physical health in surgical oncology, demonstrating that effective psychiatric treatment is not just beneficial for mood symptoms but is a critical component of improving survival and recovery after complex cancer surgeries. The findings resonate with a growing movement to view patient care through a biopsychosocial lens, advocating for interdisciplinary approaches that address the whole patient, rather than isolated disease processes.

In conclusion, depression substantially hampers recovery after major abdominal cancer surgeries in older adults. Nonetheless, antidepressant treatment appears to mitigate these effects, resulting in better surgical outcomes, shorter hospital stays, decreased readmissions, lower mortality, and reduced healthcare costs. This data underscores the imperative to prioritize mental health screening and intervention as integral aspects of perioperative care. As the healthcare community moves toward more comprehensive patient care models, such evidence could catalyze protocol changes that improve quality of life and survival rates for vulnerable populations.

Subject of Research: Impact of depression and antidepressant treatment on surgical outcomes in patients with colorectal, hepatobiliary, and pancreatic cancers.

Article Title: The Impact of Antidepressants on Surgical Outcomes in Patients with Abdominal Cancer and Comorbid Depression

News Publication Date: October 3, 2025

Web References:
– American College of Surgeons Clinical Congress 2025: https://www.facs.org/for-medical-professionals/conferences-and-meetings/clinical-congress-2025/
– Depression and sleep disruption: https://www.tandfonline.com/doi/full/10.31887/DCNS.2008.10.3/dnutt
– Depression and cancer risk: https://www.mdpi.com/2076-3425/13/2/302

References: Katayama E, et al. The Impact of Antidepressants on Surgical Outcomes in Patients with Abdominal Cancer and Comorbid Depression, Scientific Forum, American College of Surgeons (ACS) Clinical Congress 2025.

Keywords: Depression, Surgery, Antidepressants, Cancer, Colorectal Cancer, Hepatobiliary Cancer, Pancreatic Cancer, Surgical Outcomes, Postoperative Recovery, Healthcare Costs, Mental Health, Perioperative Care

Orthopedic surgeries, especially complex procedures such as osteochondral allograft transplantation, often demand rigorous postoperative adherence from patients to recovery regimens that include prescribed medications, physical therapy, and activity limitations. Despite successful surgeries, many patients fail to comply with these postoperative instructions, a phenomenon known as nonadherence. This nonadherence poses a critical threat to surgical success, being linked to an alarming 15.5-fold increase in treatment failure rates. Until recently, traditional medical evaluations paid limited attention to the psychological and social factors that potentially hinder adherence to postoperative care plans.

The recent observational study conducted by the Missouri team involved 99 patients scheduled for osteochondral allograft transplantation—a surgical technique using donor tissue to repair and restore damaged joints in the knee, hip, ankle, and shoulder. The presurgical assessment by health behavior psychologist Renee Stucky focused on comprehensive psychological profiling, including mental health evaluation and trauma history. By identifying patient-specific psychosocial barriers prior to surgery, the evaluation enabled tailored interventions aimed at enhancing patients’ commitment to their postoperative recovery plans.

One of the study’s pivotal insights was the identification of pervasive barriers that impede patient adherence. Mental health challenges, such as anxiety, depression, and previous traumatic experiences, featured prominently among these obstacles. Additionally, patients engaged in physically demanding jobs or high-energy hobbies exhibited difficulty in conforming to activity restrictions imposed after surgery. These real-world complexities illuminated the necessity of integrating behavioral health expertise into preoperative care, signaling a paradigm shift toward patient-centered, interdisciplinary treatment frameworks.

Intriguingly, the study reported only a 7% rate of surgical revision among patients who underwent the behavioral health evaluation—a significant improvement compared to historical data where nonadherence correlated strongly with failed outcomes. This finding underscores the potential efficacy of psychological interventions in mitigating risk factors that lead to surgical failure. By proactively addressing underlying psychosocial challenges, healthcare providers can increase the probability of successful recovery and reduce the burden of repeat surgeries, which often entail higher costs and prolonged patient morbidity.

Senior author James L. Cook emphasized the importance of acknowledging patients as complex individuals with multifaceted needs beyond their physical ailments. “Surgical outcomes improved when we looked at the patient as a person, rather than just focusing on the medical problem,” Cook stated. This holistic approach aligns with contemporary movements in medicine advocating for integrated care teams, combining the expertise of surgeons, psychologists, and rehabilitation specialists to optimize health outcomes through coordinated, personalized strategies.

While this study concentrated on osteochondral allograft transplantation, its implications resonate across various surgical disciplines. Psychological evaluations have previously shown promise in fields such as bariatric surgery and spinal surgeries, where patient behavior critically influences recovery trajectories. The growing body of evidence suggests that preoperative behavioral health assessments could be broadly applicable, enhancing adherence and outcomes across diverse surgical populations.

Nevertheless, challenges remain in scaling this model of care due to a limited workforce of trained behavioral health psychologists available to meet rising clinical demand. To overcome this bottleneck, researchers advocate the exploration of alternative modalities, such as structured risk assessment worksheets or preliminary screenings conducted by other allied health professionals. Systematic studies are needed to determine the effectiveness of these substitutes in accurately identifying psychosocial barriers and fostering improved postoperative behaviors.

The integration of behavioral health into orthopedic surgery not only exemplifies a patient-centered ethos but also holds the promise of economic benefits by reducing costly complications and readmissions. By preemptively addressing mental health and lifestyle factors, healthcare systems may see a reduction in treatment failures, ultimately improving patient satisfaction, functional outcomes, and quality of life. This multidimensional strategy challenges the traditional siloed approach, urging a reevaluation of how surgical success is defined and pursued.

Significant contributors to this research include Dr. Kylee Rucinski, Assistant Research Professor at the University of Missouri, who specializes in enhancing patient-centered orthopedic care, and Dr. Renee Stucky, a behavioral health psychologist whose expertise was vital in patient assessments. The collaborative nature of the study, involving orthopedic surgeons Dr. James Stannard and Dr. Clayton Nuelle, further highlights the interdisciplinary effort essential for advancing surgical medicine. Their collective work is published in the Journal of Knee Surgery, emphasizing robust, peer-reviewed validation of the findings.

As the healthcare landscape evolves towards integrative and personalized medicine, this study pioneers a new frontier where behavioral health becomes fundamental to surgical planning. The evidence strongly advocates for embedding psychological evaluations into standard preoperative protocols, emphasizing the patient’s holistic experience as central to healing. Future research and resource allocation must focus on overcoming workforce limitations and expanding access to behavioral assessments, ensuring that more patients benefit from this promising approach.

Ultimately, findings from this research challenge both clinicians and policymakers to reconsider current surgical pathways. By incorporating behavioral psychology expertise, the medical community can not only advance patient care but also address the often-overlooked determinants of surgical success. This comprehensive model promises a future in which surgeries are not just successful interventions but gateways to sustained recovery grounded in a thorough understanding of human behavior and resilience.

Subject of Research: People

Article Title: Presurgical Evaluation by a Health Behavior Psychologist Can Effectively Delineate Patient-Specific Barriers that Impact Treatment Outcomes after Osteochondral Allograft Transplantation

News Publication Date: 22-May-2025

Web References:

• University of Missouri School of Medicine: https://medicine.missouri.edu/
• Journal article DOI: http://dx.doi.org/10.1055/a-2591-9754

Keywords:
Behaviorism, Behavioral psychology, Human behavior, Allografts, Orthopedics